Session Type
Parallel Session
Date
06/28/2022
Session Time
10:35 AM - 11:05 AM
Room
Hall B
Session Description
Description:
This session will highlight the significant prothrombotic state that occurs in patients with moderate to severe COVID-19 infection, the rationale behind the initial set of guidelines, and the studies that have emerged since that time and how they have formed our current understanding and recommendations for prevention.
Learning Objectives:• Discuss the underlying pathophysiology that leads to thrombotic events in COVID-19 and how this informed the first iteration of guidelines.
• Review randomized controlled trials regarding prevention.
• Discuss current recommendations based upon this recent data, including controversies surrounding these recommendations.
Thrombosis in COVID 19 Pneumonia: What Have We Learned and How Do We Apply This?
Session Name
Session Type
Parallel Session
Date
06/28/2022
Session Time
10:35 AM - 11:05 AM
Room
Hall B
Lecture Time
10:35 AM - 11:05 AM